Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

NCT03588884 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism Due to Renal Causes
Vitamin D Insufficiency
CKD Stage 3
CKD Stage 4

Interventions

DRUG: Calcifediol Oral Capsule
DRUG: Calcifediol Oral Product
DRUG: Cholecalciferol
DRUG: Paricalcitol Oral Capsule

Sponsor

OPKO Health, Inc.